Can Philip Morris help turn tobacco into medicine?
from Investor's Business Daily
Tobacco companies have been fighting a rear-guard action in the Western world for the last few decades, facing restrictive laws and declining numbers of smokers. But what if tobacco can be used to save lives instead of take them? In December, its investment arm bought a 40 percent stake in Canadian biotech Medicago, which is developing influenza vaccines derived from tobacco plants.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063